RMI 12330A, an inhibitor of adenylate cyclase and cyclic AMP-phosphodiesterase activities in the segmental ganglia of the leech Hirudo medicinalis.
The effect of RMI 12330A, an inhibitor of basal as well as serotonin-stimulated adenylate cyclase in the segmental ganglia of the leech Hirudo medicinalis, has been tested on cyclic AMP-phosphodiesterase activity in the same tissue. The drug dose-dependently inhibits high and low affinity enzyme, an effect first evident at an RMI 12330A concentration of 0.5 mM. For both enzyme activities the drug reduces Vmax without substantially influencing Km values. Both basal and serotonin-stimulated adenylate cyclase as well as cyclic AMP-phosphodiesterase activities are inhibited by RMI 12330A in a non-competitive manner.
Biondi
C
C
Institute of General Physiology, Ferrara, Italy.
Campi
A L
AL
Pareschi
M C
MC
Portolan
A
A
Ferretti
M E
ME
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism*; D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D007097:Imines / Q000494:pharmacology*; D007865:Leeches / Q000378:metabolism*; D009420:Nervous System / Q000187:drug effects / Q000201:enzymology*
D004791:Enzyme Inhibitors; D007097:Imines; C014925:RMI 12330A; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D000262:Adenylyl Cyclases